National Heart Center/Saudi Heart Association 2025 Guidelines for Cardiovascular Diseases Prevention and Risk Assessment
Open Access
- 1 January 2026
- journal article
- practice guideline
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 47 (1) , 120-177
Abstract
Objectives: To develop an evidence-based clinical guideline for the prevention and management of cardiovascular diseases (CVDs) in Saudi Arabia, tailored to local epidemiology and healthcare needs. Methods: A multidisciplinary task force comprising cardiologists, public health specialists, and epidemiologists from different healthcare sectors in Saudi Arabia developed the guideline. Evidence synthesis was based on a comprehensive literature review and adaptation of international guidelines, particularly the 2021 European Society of Cardiology recommendations, contextualized to the Saudi setting. Results: The guideline provides recommendations for both primary and secondary CVD prevention. Primary prevention emphasizes risk assessment incorporating genetic, lifestyle, and clinical factors, as well as lipid and glucose profiling. Lifestyle modifications, including dietary changes, smoking cessation, physical activity, weight management, and psychosocial support, are prioritized. Pharmacologic therapy targets lipid levels, blood pressure, and glycemic control, tailored to individual risk categories. For secondary prevention, strategies include post-event risk stratification, comorbidity management (diabetes, hypertension, chronic kidney disease), and optimization of pharmacologic therapy for coronary artery disease, heart failure, cerebrovascular disease, and peripheral artery disease. Lifestyle interventions, supervised cardiac rehabilitation, and routine follow-up for complication monitoring and treatment adjustment are integral components. Conclusion: This guideline presents an updated, evidence-based framework specifically designed for the Saudi population, underscoring prevention, lifestyle modification, and optimized pharmacologic management to address the rising burden of CVDs.Keywords
This publication has 447 references indexed in Scilit:
- Exercise-based cardiac rehabilitation for adults with atrial fibrillationCochrane Database of Systematic Reviews, 2024
- Psychosocial Risk Factors and Cardiovascular Disease and Death in a Population-Based Cohort From 21 Low-, Middle-, and High-Income CountriesJAMA Network Open, 2021
- Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysisCochrane Database of Systematic Reviews, 2021
- Risk of ischemic stroke and utility of CHA2DS2‐VASc score in women and men with atrial fibrillationClinical Cardiology, 2019
- Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic StrokeJAMA Neurology, 2019
- Treatment in a preventive cardiology clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk‐management gaps among a primary‐prevention population compared with a propensity‐matched primary‐care cohort: A team‐based care model and its impact on lipid and blood pressure managementClinical Cardiology, 2018
- Association of “Weekend Warrior” and Other Leisure Time Physical Activity Patterns With Risks for All-Cause, Cardiovascular Disease, and Cancer MortalityJAMA Internal Medicine, 2017
- Seasonal Influenza Infections and Cardiovascular Disease MortalityJAMA Cardiology, 2016
- Added Sugar Intake and Cardiovascular Diseases Mortality Among US AdultsJAMA Internal Medicine, 2014
- Rhythm Control for Management of Patients With Atrial Fibrillation: Balancing the Use of Antiarrhythmic Drugs and Catheter AblationClinical Cardiology, 2011